Panloba
Natural health product licensed in Canada
- Other names
- Brain Health, Focus, Ginkgo Complete
- Licence holder
- St. Francis Herb Farm Inc.
- NPN or DIN-HM
- 80018282
- Status
- Active licence
- Licence date
- 3 May 2010
- Revision date
- 8 January 2021
- Form
- Teinture
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Ginkgo biloba L.: L'étiquetage des compléments alimentaires qui contiennent la feuille de la plante Ginkgo biloba L. doit comporter un avertissement avec la teneur suivante: "Consultez votre médecin en cas de prise simultanée d'anticoagulants."
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Bacopa monnieri Source : Feuille Extraction ratio : 1:4 Dry plant equivalent : 0.0475 g | 0.19 mL | Not calculated |
| Ginkgo biloba Source : Ginkgo biloba - feuille Extract : Matériel brut sec Extraction ratio : 1:4 Dry plant equivalent : 0.0875 g | 0.35 mL | Not calculated |
Non-medicinal ingredients
Eau purifiée, Éthanol
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 mL | 3 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Used in herbal medicine to help support cognitive function.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Do not use if you are taking health products that affect blood coagulation (e.g. blood thinners, clotting factor replacements, acetylsalicylic acid, ibuprofen, fish oils, vitamin E) as this may increase the risk of spontaneous bleeding. Do not take this product if you are pregnant or breastfeeding.
Source
Official Health Canada record, licence 80018282
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2021. Photograph the packaging to check whether it has changed. Photograph the packaging